Eserleri
Uluslararası Bilimsel Toplantılarda Sunulan ve Bildiri Kitabında (Proceedings) Basılan Bildiriler
B1. Kalayoğlu-Besisik S, Yurci A, Yenerel M, Kazancioglu R, Türkmen A,
Kılıcarslan Y, Sargın D. “Favorable outcome of isolated membranous nephropathy
in an allogeneic stem cell recipient”. 28rd annual Meeting of the
EBMT and 18th
Meeting of the Nurses Group, March 24-27, 2002, Montreux, Switzerland,
BONE MARROW TRANSPL 29: P786 Suppl. 2 MAR 2002
B2. Turgut M, Gelincik A, Yenerel M, Köroğlu G, Aktan M, Pekçelen Y.
“Myeloid/natural Killer cell avute leukemia: A case report.” 5th Annual
meeting of the European Haematology Association Birmingam UK, 25-28 June
2000 (p410)
B3. Kalayoğlu Beşışık S, Yavuz AS, Aktan M, Yenerel M, Sargın D, Atamer
T, Tangün Y. “Our Initial Experience With Allogeneic Bone Marrow Transplantation
(BMT) For Chronic Myelogenous Leukemia (CML).” XIIIth Meeting of The
International Society of Haematology, 3-8 September 1995, İstanbul, Abstract
book : 553 (abstract)
B4. Kalayoğlu S, Yavuz AS, Yenerel MN, Sargın D, Nalçacı M, Dinçol G,
Özbek U, Atamer T, Tangün Y: “The Role of Factor V Leiden Mutation In The
Development Of Veno-occlusive disease (VOD) After Bone Marrow Transplantation (BMT)
In A Patient With Paroxysmal Nocturnal Hemoglobinuria (PNH).” 23rd
annual Meeting of the EBMT and 13th Meeting of the Nurses Group,
March 23-27, 1997, Aix-les-Bains, France, Bone Marrow Transpantation, 19 (Suppl
1): 520 (abstract)
B5. Kalayoğlu S, Soysal T, Başlar Z, Yenerel MN, Yavuz AS, Sargın D,
Ferhanoğlu B, Atamer T, Akman N, Tangün Y: “Donor Leukocyte Infusions For Acute
Myeloid Leukemia (AML) Relapsing After Allogeneic Stem Cell Transplantation (SCT).”
23rd
annual Meeting of the EBMT and 13th Meeting of the Nurses Group,
March 23-27, 1997, Aix-les-Bains, France, Bone Marrow Transpantation, 19 (Suppl
1): 545 (abstract)
B6. Kalayoğlu Beşışık S, Yenerel MN, Budak Alpdoğan T, Yavuz AS, Sargın
D, Tangün Y: “Allogeneic Peripheral Blood Stem Cell Transplantation (allo-PBSCT)
Versus Allogeneic Bone Marrow Transplantation (allo-BMT). Rapid Engraftment But
Increased Morbidity Due To GVHD:” 2nd International Symposium on
Allogeneic Peripheral Blood and Cord Blood Transplantaiton, Geneva, October
30-November 1, 1997, Final program and abstracts: 38 (abstract)
B7. Kalayoğlu Beşışık, Budak Alpdoğan T, Yenerel MN, Altay S, Sargın D,
Tangün Y: “Thrombocytopenia In Allogeneic Peripheral Blood Stem Cell
Transplantation (allo-PBSCT) Donors.” 2nd International Symposium
on Allogeneic Peripheral Blood and Cord Blood Transplantaiton, Geneva,
October 30-November 1, 1997, Final program and abstracts: 6 (abstract)
B8. Kalayoğlu-Beşışık S, Yenerel MN, Budak-Alpdoğan T, Sargın D, Tangün
Y. “Incidence and Severity Of GVHD In Allogeneic Peripheral Blood Stem Cell
Transplantation (ALLO-PBSCT). Analysis of 21 Patients.” American Society of
Hematology, Thirty-Ninth annual Meeting, December 5-9, 1997, Sandiego, CA.
Blood 1997; 90:(suppl 1) 4495 (abstract)
B9. Yenerel MN, Kalayoğlu Beşışık S, Budak Alpdoğan T, Sargın D, Tangün
Y. “The Value Of Reticulocyte Maturity Index (RMI) As A Predictor Of Engraftment
In Allogeneic Peripheral Blood Stem Cell Transplantation (ALLO-PBSCT).” 24th
Annual Meeting of the EBMT and 14th Meeting of the Nurses Group,
March 22-26 1998, Courmayeur, Italy, Bone Marrow Transplantation, 21 (Suppl 1):
264 (abstract)
B10. Budak Alpdoğan T, Yenerel MN, Kalayoğlu Beşışık S, Yanaşık M, Sargın
D, Tangün Y. “The Influence Of Flow cytometric (FC) Gating Strategy And Cell
Preparation Procedures On CD34+ Cell Enumeration.” 24th Annual
Meeting of the EBMT and 14th Meeting of the Nurses Group, March
22-26 1998, Courmayeur, Italy, Bone Marrow Transplantation, 21 (Suppl 1): 686 (abstract)
B11. Kalayoğlu Beşışık S, Yenerel MN, Budak Alpdoğan T, Sargın D, Tangün
Y. “Graft Versus Myeloma Effect Augmented By Donor Leukocyte Infusions (DLI)
Following An Incomplete Response To Allogeneic Blood Stem Cell Transplantation (ALLO-BSCT).”
24th Annual Meeting of the EBMT and 14th Meeting of the
Nurses Group, March 22-26 1998, Courmayeur, Italy, Bone Marrow
Transplantation, 21 (Suppl 1): 748 (abstract)
B12. M. N. Yenerel, I. Hatemi, H. Keskin. “Concomittant chronic
lymphocytic leukemia and acute Myeloid Leukemia, Diagnosed by Two Color Flow
Cytometric Analysis.”
Combined Hematology Congress of ISH-EHA 4-8 July 1998, Final program and
abstracts: 0803 (abstract)
B13. Ozbek U, Kalayoglu-Besisik S, Aydin M, Yenerel M, Aktan H, Budak T,
Yavuz S, Tangun Y, Sargin D. “Chimerism status in allo-PBSCT versus allo-BMT:
Single center results”. American Society of Hematology, 42nd annual Meeting.
BLOOD
96: (11) 5271 , Part 2 NOV 16 2000
B14. Nagel T, Kim HC, Yenerel M, Pekcelen Y, Mahley RW, Afshar-Kharghan
V, Lopez JA “Bernard-Soulier syndrome caused by a novel insertional mutation in
the glycoprotein IB alpha gene.” The international society of thrombosis and
haemostasis XVth congress. THROMBOSIS AND HAEMOSTASIS , 2180 , Suppl. S
AUG 1999
B15. M. N. Yenerel, M. Nalçacı, M. Aktan, S. Yavuz, H. Keskin, D. Sargın,
T. Atamer, G. Diçol, Y. Pekçelen. “Adult T Cell Acute Lymphoblastic Leukemia:
Clicinal Parameters and Outcome.” Combined Hematology Congress of ISH-EHA
4-8 July 1998, Final program and abstracts: 0914 (abstract)
B16. M. N. Yenerel, M. Nalçacı, T. Atamer, Y. Pekçelen. “Clinical and
Hematological Study of 11 Patients With Paroxysmal Nocturnal Hemoglobinuria”.
Combined Hematology Congress of ISH-EHA 4-8 July 1998, Final program and
abstracts: 1230 (abstract)
B17. Nagel T, Yenerel M, Diz-Küçükkaya R, Pekçelen Y, Hiçsönmez G, Kim HC,
Pepin J, Mahley RW, Afshar-Kharghan V, López JA: “Bernard-Soulier syndrome:
Differential platelet glycoprotein Ib-IX-V expression in five distinct Turkish
kindreds.”
American Society of Hematology (ASH), 40th Annual Meeting, Miami Beach, USA,
December 4-8, BLOOD, 92, 133, 1998
B18. Besisik S, Budak T, Yenerel M, Sargin D, Tangun Y. “The source of
stem cells (BMT versus PBSCT) in adult allogeneic transplantation does not only
predict the incidence of chronic GVHD but also the outcome of the transplant.”
25th
Annual Meeting of the EBMT and 15th Meeting of the Nurses Group BONE
MARROW TRANSPLANTATION 23: 292 , Suppl. 1 MAR 1999
B19. Reyhan Diz Küçükkaya, Abdullah Hacıhanefioğlu, Mustafa Nuri Yenerel,
Mehmet Turgut, Hüseyin Keskin, Meliha Nalçacı, Murat İnanç. “Antiphospholipid
syndrome in patients presented with immune thrombocytopenic purpura: A
prospective cohort study“, (9th International Symphosium on
Antiphospholipid Antibodies, Tours), J Autoimmunity, 15, P163, 2000.
B20. Atamer T, Yenerel MN, Yavuz AS, Küçükkaya R, Beşışık S, Aktan M,
Keskin H, Nalçacı M, Sargın D, Pekçelen Y, Dinçol G: “Thrombotic complications
in essential thrombocythemia.” American Society of Hematology (ASH), 43rd
Annual Meeting, December 7-11,2001, Florida, USA. BLOOD 98
(11): 4848 Part 2 NOV 16 2001.
B21. Ahmet Torun, SevgiKalayoğlu-Beşışık, Emine Ozkan, Pınar Basaran, Mustafa
N. Yenerel, Mehmet A. Karan, Gülden Yılmaz, Deniz Sargın. “HHV-8 is not
ubiquotus in turkish multiple myeloma patients as determined by nested PCR and
also serological analysis.” American Society of Hematology (ASH), 43rd Annual
Meeting, December 7-11,2001, Florida, USA. BLOOD 98 (11): 4972
Part 2 NOV 16 2001.
B22. Yenerel MN, Atamer T, Yavuz AS, Küçükkaya R, Beşışık S, Aktan M,
Keskin H, Nalçacı M, Sargın D, Pekçelen Y, Dinçol G: “Myeloid antigen expression
provides favorable outcome in patients with adult acute lymphoblastic leukemia:
A single center study.” American Society of Hematology (ASH), 43rd Annual
Meeting, December 7-11,2001, Florida, USA. BLOOD 98 (11): 4542
Part 2 NOV 16 2001.
B23. Pekcelen Y, Atamer T, Nalcaci M, Yavuz S, Diz-Kucukkaya R, Aktan M, Yenerel
MN, Sargin D, Keskin H: Thrombotic thrombocytopenic purpura: Long-term results
of splenectomy. 27th Congress of the International Society of Blood Transfusion,Vancouver,
British Columbia, August 24-29, 2002
B24. Sundell-Ranby B, Yenerel MN, Shim MH, et al. Beta adducin gene
expression is suppressed during megakaryopoiesis. BLOOD 102 (11): 160B-160B 4351
Part 2 NOV 16 2003
B25. Kalayoglu-Besisik S, Erer B, Savran-Oguz F, et al. The association of HLA
class I antigens and class II alleles with multiple myeloma in Turkey. BLOOD 102
(11): 374B-375B 5226 Part 2 NOV 16 2003
B26. Atamer TA, Yenerel MN, Aydin F, Eskinazi N, Diz-Kucukkaya R, Arti-
Esen B, Dogan O, Agan M: Transfusion associated graft versus host disease in
four immunocompetent patients. 11th Congress of the European Hematology
Association, Amsterdam June 15-18, 2006. Hematology Journal 91(s1): 203, 2006
B27. Yenerel MN, Diz-Kucukkaya R, Demirel N, Ayer M, Yavuz S, Besısık S,
Aktan M, Nalçaci M, Sargin D, Atamer T, Pekcelen Y, Dincol G: Does previous
interferon use have negative effect on imatinib response in chronic myeloid
leukemia(CML)? A single center study. American Society of Hematology (ASH), 48th
Annual Meeting, 2006
B28. M.N. Yenerel, E. Gul, M. Nalcaci, R. Diz-Kucukkaya, M.G. Gulluoglu.
Secondary systemic amyloidosis in Hodgkin’s Disease: a case report and review.6th
Congress European Federation of Internal Medicine, Lisbon, 2007;p07-07:sayfa 140
B29. M.N. Yenerel, V. Sensoy, Kocaoglu M, Atamer T. Post-transfusion
purpura: a case report. 6th Congress European Federation of Internal Medicine,
Lisbon, 2007;p21-05:sayfa 197
B30. Mustafa Yenerel, Serdar Sahinoglu, Oner Dogan, Reyhan Diz-Kucukkaya,
Meliha Nalcaci. Pulmonary involvement in Hodgkin Disease. 1st International
leukemia-lymphoma-Myeloma (LLM) congress 2007, poster no: 41
B31. Mustafa Yenerel, Esra Hatipoglu, Abdullah Ozkok, Tanju Atamer.
Autoimmune hemolytic anemia after cladribine therapy for Hairy cell Leukemia.
1st International leukemia-lymphoma-Myeloma (LLM) congress 2007, poster no: 60
B32. Nazligul E, Palanduz S, Ozturk S, Bayrak A, Ucur A, Bagatir G, Cefle K,
Yenerel M, Nalcaci M. The evaluation of the genomic instability by
micronucleus and sister chromatid exchange in myelodysplastic syndrome.
CHROMOSOME RESEARCH. 17: Suppl. 1; 137-138, 2009